Donald M. Arnold retweeted
Platelet immunology SSC at @isth standardizing HIT and VITT testing
Donald M. Arnold retweeted
the McMaster Platelet Immunology Lab is a 2021 recipient of the @McMasterU
President’s Awards for Outstanding Service in the Team Award category! kudoboard.com/boards/2VgMLHZ…
@MacDeptMed @MacPlateletLab @Mac_Transfusion @McMasterIIDR @MacGlobalNexus @machealthsci @fordnation
Donald M. Arnold retweeted
Smiling because votes count double today ⭐️
@FredVanVleet | #NBAAllStar
⭐️ 1 RT = 2 VOTES ⭐️
Donald M. Arnold retweeted
Therapeutics are here and continue to come down the pipeline. They won't solve ongoing community transmission, but systems to support their use will help with ensuring our highest risk populations have benign outcomes. We need to step up.
theglobeandmail.com/opinion/…
Donald M. Arnold retweeted
Very proud moment to have John Vrbensky successfully defend his PhD thesis @MacPlateletLab @Mac_Transfusion @arnolddma1 @PatriciaLiaw
Donald M. Arnold retweeted
Something special being in the @TheSpec. I’m Hamilton born and bred and @McMasterU educated, trained and employed. ‘Nature’ fast-tracks publishing McMaster’s research on vaccine-induced blood clots - thespec.com thespec.com/news/hamilton-re…
Donald M. Arnold retweeted
.@McMasterU researchers map out how some @COVID19 vaccines trigger rare blood clotting reactions | CBC News #HamOnt cbc.ca/news/canada/hamilton/…
Donald M. Arnold retweeted
McMaster researchers have pinpointed the exact cause of rare vaccine-related blood clots – paving the way for better diagnosis and treatments. | @ishacgaby @MacGlobalNexus @machealthsci brighterworld.mcmaster.ca/ar…
Donald M. Arnold retweeted
McMaster team closes in on cause of rare AstraZeneca-related blood clots dlvr.it/S3DDzG
Donald M. Arnold retweeted
New research into rare blood clots associated with the AstraZeneca Covid-19 vaccine identified specific amino acids targeted by antibodies in recipients of the shot on.wsj.com/3xq8TaB
Donald M. Arnold retweeted
Congrats @McMasterU Platelet Immunology Laboratory for outstanding research on how Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) is triggered, opening pathways to explore prevention, treatment & improved vaccine safety.
teapaw.org/McMasterU/status/14127…
McMaster researchers have pinpointed the exact cause of rare vaccine-related blood clots – paving the way for better diagnosis and treatments. | @ishacgaby @MacGlobalNexus @machealthsci brighterworld.mcmaster.ca/ar…
Donald M. Arnold retweeted
For all my Lab Peeps — See below for a great opportunity to work in the internationally recognized Platelet Immunology Lab @McMasterU with @MacDeptMed @ishacgaby @Mac_Transfusion @arnolddma1 and many more ... if interested please contact @medlabmaria @ishacgaby
This Post is from an account that no longer exists. Learn more
Donald M. Arnold retweeted
Launch of Ontario's Massive Hemorrhage Protocol recommendations via @ORBCoN1 today!
Several years of work, lead by Drs @JeannieCallum & Katerina Pavenski. Amazing provincial effort that will undoubtedly improve care of bleeding patients in Ontario!
transfusionontario.org/en/ca…
Donald M. Arnold retweeted
Dr. Samir Gupta explains how the four COVID-19 vaccines now approved in Canada work and why efficacy rates aren’t the most important number to look at.
Which COVID-19 vaccine is better? (spoiler, they’re all good)
Donald M. Arnold retweeted
Uber-smart @MacDeptMed Dr. Donnie Arnold describing RARE AZ vax side effects @CTVNews
Bottom line: benefits >>> risks 👍🥳🇨🇦
Donald M. Arnold retweeted
McMaster scientist resolves COVID-19 clot question newswise.com/coronavirus/mcm… @MacDeptMed @Mac_Transfusion @McMasterU @machealthsci @COVIDimmunityTF @TheSpec @CBCHamilton
Donald M. Arnold retweeted
'Spit study' makes COVID-19 testing easier hamiltonnews.com/community-s… via @@HamOntComNews
Donald M. Arnold retweeted
Need to see this data obviously but this is amazing. A cheap readily available drug with clinical experience that prevents hospitalization and end organ dysfunction.
Hope in darker times until the vaccine catches up thecanadian.news/2021/01/23/…
Donald M. Arnold retweeted
Full-dose blood thinners decreased need for life support and improved outcome in hospitalized COVID-19 patients. Congrats to the multiplatform trial investigators! nih.gov/news-events/news-rel…




















